Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Study provides translational and mechanistic support for Phase 2 trial results of Mesoblast’s cell therapy in patients with biologic refractory rheumatoid arthritis MELBOURNE, Australia and NEW YORK,...
-
Sydney, Australia, Feb. 09, 2017 (GLOBE NEWSWIRE) -- Heron Resources Limited (“Heron”) is pleased to announce that the share sale facility (“Facility”) established by Heron and undertaken by Euroz...
-
TORONTO, Feb. 06, 2017 (GLOBE NEWSWIRE) -- Alacer Gold Corp. (“Alacer” or the “Corporation”) (TSX:ASR) and (ASX:AQG) announced today that it has filed its operating and financial...
-
NEW YORK and MELBOURNE, Australia, Jan. 31, 2017 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO) (ASX:MSB) today announced that its non-executive Director, Dr Eric A. Rose, was awarded the 2017...
-
Sydney, Australia, Jan. 30, 2017 (GLOBE NEWSWIRE) -- Heron Resources Ltd. (TSX: HER) (ASX: HRR) ("Heron" or the "Company") announces its quarterly activities for the three months...
-
SYDNEY, Australia, Jan. 26, 2017 (GLOBE NEWSWIRE) -- Audio Pixels Holdings Limited (ASX:AKP) (OTC:APDXY), a leader in the digital transition of loudspeakers today announced that one of its...
-
Sydney, Australia, Jan. 23, 2017 (GLOBE NEWSWIRE) -- Heron Resources Limited (“Heron”) is pleased to announce that each of the conditions to the spin-off of Ardea Resources Limited (“Ardea”) have...
-
TORONTO, Jan. 19, 2017 (GLOBE NEWSWIRE) -- Alacer Gold Corp. (“Alacer” or the “Corporation”) (TSX:ASR) (ASX:AQG) plans to release its fourth quarter 2016 operating results, financial...
-
MELBOURNE, Australia, Jan. 19, 2017 (GLOBE NEWSWIRE) -- Australian biopharmaceutical Company Immuron Limited (ASX:IMC) is pleased to announce the initiation of several studies designed to add to the...
-
MELBOURNE, Australia and DRESDEN, Germany, Jan. 18, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”) is pleased to announce a product development partnership with Therapeia GmbH...